Cochlear (ASX:COH) Accounts Payable & Accrued Expense : A$247 Mil (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Cochlear Accounts Payable & Accrued Expense?

Cochlear's quarterly accounts payable & accrued expense increased from Dec. 2022 (A$201 Mil) to Jun. 2023 (A$270 Mil) but then declined from Jun. 2023 (A$270 Mil) to Dec. 2023 (A$247 Mil).

Cochlear's annual accounts payable & accrued expense increased from Jun. 2021 (A$203 Mil) to Jun. 2022 (A$232 Mil) and increased from Jun. 2022 (A$232 Mil) to Jun. 2023 (A$270 Mil).

Cochlear Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cochlear's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cochlear Accounts Payable & Accrued Expense Chart

Cochlear Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

160.80

159.30

202.90

232.40

270.40

Cochlear Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															169.80	232.40	201.20	270.40	247.10

Cochlear Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cochlear (ASX:COH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (ASX:COH) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CHEOY:USA CHEOF:USA OC5:Germany

Address

1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109

Website

https://www.cochlear.com

Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.

Cochlear (ASX:COH) Headlines

No Headlines